Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth

Sponsor
University of Pennsylvania (Other)
Overall Status
Recruiting
CT.gov ID
NCT05230004
Collaborator
Children's Hospital of Philadelphia (Other)
10
1
1
12
0.8

Study Details

Study Description

Brief Summary

An immediate fit adjustable prosthetic system is being investigated for children. The age range being recruited is from 3 years up to 12 years old. Phase I of this study will involve developing a final prototype by conducting in-lab testing on children with limb loss. A questionnaire, socket pressure measures and biomechanical gait analysis will be conducted.

The aim is to develop appropriate sizes of the prosthetic and arrive at a final design.

Condition or Disease Intervention/Treatment Phase
  • Device: iFIT prosthesis
N/A

Detailed Description

Design Phase I is a testing session to obtain feedback on initial prototype designs for the immediate fit prostheses. This research will focus on PI observations and participant feedback through survey and comments during the in-person testing. There may be multiple appointments for participants during this time the device design is refined. In-lab testing only will occur. This information will influence the overall design of the final prosthesis.

PHASE I: For Phase I children with lower limb limb loss (below the knee or above the knee) age 3-12 are being recruited. Subjects should be able to ambulate with or without assistive devices. They will supply measurements and limb images prior to the appointment.

During the initial appointment, each participant will be consented and completed roughly 2-3 hours of device testing. The participant will be fit with an adjustable prosthetic by the PI. After ambulating in the lab, they will give feedback on the comfort, stability and ease of use of the prosthesis. Participants may be asked to return several times for future testing sessions once changes or alterations are made to the prosthesis design to see if these have been effective. The child and their parent will fill out a PEQ based questionnaire on their conventional prosthesis and the investigational device after fitting.

A gait biomechanical analysis will be conducted by having several reflective markers placed on the participant's lower body. The subject will then walk a minimum of 6 times along a 10meter walk-way while being recorded by the motion analysis system. This will be conducted in both the test and conventional prosthesis.

Internal pressure measurements of the socket using Fujifilm pressure paper will also be obtained. Five spots will be assessed by placing the paper on the participant's liner and then they will put on their socket and walk for 30 seconds. This will be completed on both the test and conventional socket.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Phase I

Phase I involves testing the comfort and feasibility of our adjustable prosthetic system for children. This arm will involve in-lab testing only to arrive at a final design. Feedback will be obtained verbally and through the PEQ questionnaire to determine comfort, stability and feasibility of the adjustable system.

Device: iFIT prosthesis
An adjustable modular prosthesis that can be fit in a single session. Fully adjustable by wearer.

Outcome Measures

Primary Outcome Measures

  1. Modified Prosthetic Evaluation Questionnaire [1 day]

    Evaluation questionnaire for prosthesis. Questions selected from PEQ are rated from 1-poor, to 5 excellent. 70 points total

  2. Internal Socket Pressures [1 day]

    Fujifilm pressure paper will be taped to the inside of the conventional socket and test socket to determine internal pressure values. Participants will walk at a self selected walking speed for 30 seconds.

  3. Socket Comfort Score [1 day]

    Rating of socket comfort from 0 very uncomfortable to 10 very comfortable

  4. Gait Speed [1 day]

    Participants will walk at a self-selected walking speed while being recorded by 3d motional analysis cameras. They will walk across a 10 meter runway six times in their conventional socket and six times in the test socket to determine average walking speed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Four months post-amputation

  • Subjects who have lost a limb due to any cause: trauma, congenital limb loss, dysvascular causes (peripheral vascular disease and diabetes), or malignancy will all be eligible for inclusion.

  • Intact, protective sensation in their residual limbs.

Exclusion Criteria:
  • open skin lesions

  • excessive pain in the residual limb (phantom pain, residual limb pain, or neuroma)

  • neurological disorders (e.g., stroke, severe polyneuropathy) causing weakness in the contralateral leg or marked gait impairment

  • inability to follow instructions for trial

Contacts and Locations

Locations

Site City State Country Postal Code
1 Penn Medicine Rittenhouse Philadelphia Pennsylvania United States 19146

Sponsors and Collaborators

  • University of Pennsylvania
  • Children's Hospital of Philadelphia

Investigators

  • Principal Investigator: Timothy R Dillingham, MS,MD, University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Timothy Dillingham, The William J. Erdman II, Professor and Chair, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT05230004
Other Study ID Numbers:
  • 849980
First Posted:
Feb 8, 2022
Last Update Posted:
Feb 25, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Timothy Dillingham, The William J. Erdman II, Professor and Chair, University of Pennsylvania

Study Results

No Results Posted as of Feb 25, 2022